Letters to the Editor

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor

NHLBI, NIDDK, National Institutes of Health (NIH), Bethesda, USA;
NHLBI, NIDDK, National Institutes of Health (NIH), Bethesda, USA;
Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, USA;
Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, USA;
Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, USA;
Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, USA;
Department of Pharmacy, National Institutes of Health Clinical Center, Bethesda, MD;
Hematology Branch, NHLBI, NIH, Bethesda, USA;
NHLBI, NIDDK, National Institutes of Health (NIH), Bethesda, USA;
NHLBI, NIDDK, National Institutes of Health (NIH), Bethesda, USA;
Department of Hematology, St. Jude Children Research Hospital (SJCRH), Memphis, USA;
Department of Hematology, St. Jude Children Research Hospital (SJCRH), Memphis, USA;
Department of Bone Marrow Transplantation and Cellular Therapy, SJCRH, Memphis, USA
Department of Hematology, St. Jude Children Research Hospital (SJCRH), Memphis, USA;
Department of Hematology, St. Jude Children Research Hospital (SJCRH), Memphis, USA;
NHLBI, NIDDK, National Institutes of Health (NIH), Bethesda, USA;
NHLBI, NIDDK, National Institutes of Health (NIH), Bethesda, USA;
Haematologica Early view Feb 13, 2020 https://doi.org/10.3324/haematol.2019.236182